Skip to main content

Table 1 Comparison between Gullian Barré patients and control subjects at initial assessment

From: Sleep and psychiatric abnormalities in Gullian Barré Syndrome

 

Patients

Control

ANOVA

 

Mean ± SD

Mean ± SD

f value

p value

Overall Disability Sum Score

Early

5.95 ± 0.82

0.7 0 ± 0.82

156.47

> 0.0001*

Late

4.15 ± 0.67

> 0.0001*

Neuropathy Pain Scale

Early

17.35 ± 8.28

9.0 ± 3.59

10.09

0.004*

Late

9.15 ± 5.02

0.998

Hamilton Anxiety Scale

Early

25.9 ± 5.7

7.7 ± 2.16

22.5

> 0.0001*

Late

21.15 ± 5.54

> 0.0001*

MADRS

Early

18.9 ± 9.96

7.4 ± 5.08

6.74

0.002*

Late

15.55 ± 7.12

0.033*

Mean sleep latency of MSLT (min)

Early

11.79 ± 3.97

16.64 ± 2.2

6.79

0.002*

Late

14.23 ± 3.45

0.185

Total sleep time (hours)

Early

5.28 ± 0.43

7.29 ± 0.33

70.49

> 0.0001*

Late

5.64 ± 0.49

> 0.0001*

Wake after sleep onset (hours)

Early

2.91 ± 0.588

0.85 ± 0.34

64.66

> 0.0001*

Late

2.53 ± 0.41

> 0.0001*

Sleep efficiency (%)

Early

62.56 ± 5.93

86.38 ± 4.22

74.44

> 0.0001*

Late

67.53 ± 4.57

> 0.0001*

SSTI (No of sleep stages/h)

Early

21.9 ± 6.51

8.6 ± 1.6

24.5

> 0.0001*

Late

19.74 ± 4.36

> 0.0001*

Apnea hypopnea index (/hour)

Early

19.11 ± 7.75

5.67 ± 5.46

16.64

> 0.0001*

Late

18.2 ± 5.15

> 0.0001*

Pulse Transit Time (msec)

Early

184.6 ± 23.2

241.4 ± 13.2

13.6

> 0.0001*

Late

232.3 ± 12.3

> 0.0001*

Arousal index (/hour)

Early

37.6 5 ± 12.69

5.5 ± 2.63

33.64

> 0.0001*

Late

35.4 ± 10.98

> 0.0001*

Snore Index (/hour)

Early

299.3 ± 142.25

29.1 ± 21.89

22.53

> 0.0001*

Late

234.45 ± 81.66

> 0.0001*

Periodic limb movements index (/hour)

Early

46.35 ± 22.61

9.9 ± 3.66

13.29

> 0.0001*

Late

41.0 ± 18.92

> 0.0001*

  1. Early after admission and before immunotherapy, Late 1 month after immunotherapy, MADRS Montgomery–Åsberg Depression Rating Scale, MSLT multiple sleep latency test, SSTI sleep stage transition index
  2. *Significant